Z08: Encounter for follow-up examination after completed treatment for malignant neoplasm

Z08, encounter for follow-up examination after completed treatment for malignant neoplasm, is listed as a covered diagnosis in 11 Medicare billing and coding articles that apply to 64 HCPCS Level II codes, including J0153 (Injection, adenosine, 1 mg (not to be used to report any…), J1250 (Injection, dobutamine hydrochloride, per 250 mg), J1245 (Injection, dipyridamole, per 10 mg). The articles come from 4 Medicare contractors. A listed diagnosis supports medical necessity only; coverage still depends on the LCD's criteria and on documentation in the medical record.

HCPCS Level II codes with Z08 as a covered diagnosis

CodeDescriptionMedicare coverageDMEPOS fee 2026 (state range)Articles listing it
J0153Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds)Special coverage instructions apply—6
J1250Injection, dobutamine hydrochloride, per 250 mgSpecial coverage instructions apply—6
J1245Injection, dipyridamole, per 10 mgSpecial coverage instructions apply—6
A9500Technetium tc-99m sestamibi, diagnostic, per study doseCarrier judgment—3
A9502Technetium tc-99m tetrofosmin, diagnostic, per study doseCarrier judgment—3
A9505Thallium tl-201 thallous chloride, diagnostic, per millicurieCarrier judgment—3
A9501Technetium tc-99m teboroxime, diagnostic, per study doseCarrier judgment—3
A9512Technetium tc-99m pertechnetate, diagnostic, per millicurieCarrier judgment—2
A9560Technetium tc-99m labeled red blood cells, diagnostic, per study dose, up to 30 millicuriesCarrier judgment—2
A9538Technetium tc-99m pyrophosphate, diagnostic, per study dose, up to 25 millicuriesCarrier judgment—2
J3490Unclassified drugsSpecial coverage instructions apply—2
J0461Injection, atropine sulfate, 0.01 mgSpecial coverage instructions apply—4
J0280Injection, aminophyllin, up to 250 mgSpecial coverage instructions apply—4
J2785Injection, regadenoson, 0.1 mgCarrier judgment—2
G0279Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066)Carrier judgment—1
C8903Magnetic resonance imaging with contrast, breast; unilateralSpecial coverage instructions apply—1
C8905Magnetic resonance imaging without contrast followed by with contrast, breast; unilateralSpecial coverage instructions apply—1
C8906Magnetic resonance imaging with contrast, breast; bilateralSpecial coverage instructions apply—1
C8908Magnetic resonance imaging without contrast followed by with contrast, breast; bilateralSpecial coverage instructions apply—1
A9520Technetium tc-99m tilmanocept, diagnostic, up to 0.5 millicuriesCarrier judgment—1
C9176Tc-99m from domestically produced non-heu mo-99, [minimum 50 percent], full cost recovery add-on, per study doseSpecial coverage instructions apply—1
A9700Supply of injectable contrast material for use in echocardiography, per studySpecial coverage instructions apply—2
A9555Rubidium rb-82, diagnostic, per study dose, up to 60 millicuriesCarrier judgment—1
A9526Nitrogen n-13 ammonia, diagnostic, per study dose, up to 40 millicuriesCarrier judgment—1
A4641Radiopharmaceutical, diagnostic, not otherwise classifiedCarrier judgment—1

39 more codes are listed. See every code with payment by region in Caduvo.

Medicare policy articles listing Z08

A diagnosis listed as covered in a billing and coding article supports medical necessity for the article's codes; it does not guarantee payment. Coverage depends on the LCD's criteria, the contractor's jurisdiction and documentation in the medical record.

Frequently asked questions

Does Medicare cover Z08 (Encounter for follow-up examination after completed…)?

Medicare covers items and services, not diagnoses. 11 Medicare billing and coding articles list Z08 as a covered diagnosis for 64 HCPCS Level II codes: the diagnosis can support medical necessity for those codes, but payment still depends on the LCD's coverage criteria and the medical record.

Which HCPCS codes can be billed with ICD-10 Z08?

The Level II codes from the policies most specific to this diagnosis are J0153 (Injection, adenosine, 1 mg (not to be used to report any…, 6 articles); J1250 (Injection, dobutamine hydrochloride, per 250 mg, 6 articles); J1245 (Injection, dipyridamole, per 10 mg, 6 articles); A9500 (Technetium tc-99m sestamibi, diagnostic, per study dose, 3 articles); A9502 (Technetium tc-99m tetrofosmin, diagnostic, per study dose, 3 articles). Code choice depends on the item supplied; check each code's descriptor.

Which Medicare policy articles list Z08?

A56494 (Billing and Coding: Cardiovascular Nuclear Medicine); A56448 (Billing and Coding: Breast Imaging Mammography/Breast Echography (Sonography)/Breast MRI/Ductography); A56743 (Billing and Coding: Cardiovascular Nuclear Medicine), and 8 more articles.

What is ICD-10-CM code Z08?

Z08 is the ICD-10-CM code for encounter for follow-up examination after completed treatment for malignant neoplasm, in category Z08 (Encounter for follow-up examination after completed treatment for malignant neoplasm), chapter 22: Factors influencing health status and contact with health services.

Next steps

Sources: CMS Medicare Coverage Database billing and coding articles (covered ICD-10 code lists and HCPCS links); ICD-10-CM FY2026; CMS HCPCS Level II release October 2026; CMS DMEPOS fee schedule 2026 (non-rural state fees). Not billing or legal advice.

Chapter 22: Factors influencing health status and contact with health services · All diagnoses · HCPCS lookup